uracil has been researched along with Bone Cancer in 42 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 9.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| "This study compared the efficacy of regorafenib and trifluridine/tipiracil (TFTD) in patients with metastatic colorectal cancer (mCRC) who are refractory to standard chemotherapy, because despite their clinical approval, it still remains unclear which of these two drugs should be used as initial treatment." | 7.88 | Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study. ( Baba, E; Denda, T; Enomoto, M; Esaki, T; Fukuoka, S; Gosho, M; Ishikawa, T; Kajiwara, T; Kashiwada, T; Komatsu, Y; Kumekawa, Y; Makiyama, C; Moriwaki, T; Okuyama, H; Sakai, D; Satake, H; Shimada, Y; Sugimoto, N; Sugiyama, M; Suto, T; Takashima, A; Tamura, T; Taniguchi, H; Watanabe, T; Yamashita, K; Yamazaki, K, 2018) |
| "A 51-year-old female with advanced breast cancer involving multiple bone metastases was daily administered 400 mg of UFT and 20 mg of tamoxifen." | 7.67 | [A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen]. ( Endo, F; Ishii, T; Kito, T, 1989) |
| "We recently established a metastasis model in nude mice using the MKL-4 cell line, a contransfectant of the MCF-7 human breast cancer cell line with fgf-4 and lacZ in which micrometastases in several organs can be quantitatively observed." | 5.30 | Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice. ( Dickson, RB; Fujioka, A; Fukumori, H; Kurebayashi, J; Kurosumi, M; Nukatsuka, M; Saito, H; Sonoo, H; Takeda, S; Unemi, N, 1997) |
| "The aim was to determine the recommended dose of combined chemotherapy with mitoxantrone and uracil/tegafur (Phase I part) and to clarify its efficacy and safety in patients with advanced hepatocellular carcinoma at the recommended dose (Phase II part)." | 5.15 | A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Mitsunaga, S; Morizane, C; Nakachi, K; Okusaka, T; Suzuki, E; Ueno, H, 2011) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "This study compared the efficacy of regorafenib and trifluridine/tipiracil (TFTD) in patients with metastatic colorectal cancer (mCRC) who are refractory to standard chemotherapy, because despite their clinical approval, it still remains unclear which of these two drugs should be used as initial treatment." | 3.88 | Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study. ( Baba, E; Denda, T; Enomoto, M; Esaki, T; Fukuoka, S; Gosho, M; Ishikawa, T; Kajiwara, T; Kashiwada, T; Komatsu, Y; Kumekawa, Y; Makiyama, C; Moriwaki, T; Okuyama, H; Sakai, D; Satake, H; Shimada, Y; Sugimoto, N; Sugiyama, M; Suto, T; Takashima, A; Tamura, T; Taniguchi, H; Watanabe, T; Yamashita, K; Yamazaki, K, 2018) |
| "A 34-year-old female patient with breast cancer metastasizing to bone had a remission after a course of treatment with medroxyprogesterone acetate (MPA) 1,200 mg/day, but again had a metastasis to the lungs." | 3.68 | [A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy]. ( Harada, N; Kanda, K; Kida, H; Narita, K; Uchimura, M; Waki, S, 1990) |
| "A 51-year-old female with advanced breast cancer involving multiple bone metastases was daily administered 400 mg of UFT and 20 mg of tamoxifen." | 3.67 | [A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen]. ( Endo, F; Ishii, T; Kito, T, 1989) |
| "More than two-thirds of patients with gastric cancer present with metastatic disease and their curative options are limited." | 2.73 | Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer. ( Baruch, NB; Biran, H; Dinerman, M; Idelevich, E; Karminsky, N; Katsenelson, RL; Man, S; Shani, A; Zvi, NB, 2007) |
| "According to the Japan Mammary Cancer Society's criteria of response, more than partial response was observed in 11 out of 32 cases (34." | 2.65 | [Clinical trial of UFT against disseminated breast cancer]. ( Harauchi, D; Itoh, S; Konishi, Y; Shinoto, M, 1984) |
| "The tegafur-uracil treatment resulted in the disappearance of pulmonary metastases, and a stabilization of the bone metastases." | 1.40 | [A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival]. ( Abiko, M; Harada, M; Sato, T; Shiono, S; Takanashi, I, 2014) |
| " Furthermore, she was administered tegafur/uracil (400 mg/day) 5 days weekly for pharmacokinetic modulating chemotherapy (PMC)." | 1.33 | [A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy]. ( Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T, 2005) |
| "A 54-year-old woman who had ascending colon cancer with multiple liver and lung metastases underwent rt." | 1.33 | [A case of colon cancer with multiple liver, lung and bone metastases successfully treated with combined weekly high-dose 5-FU (WHF) chemotherapy with UFT and CPT-11]. ( Fujii, Y; Kobayashi, T; Kuga, T; Matsuoka, T; Morikage, N; Nakayama, T, 2005) |
| "We report a rare patient with a DPD deficiency." | 1.33 | [A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency]. ( Arai, K; Hashimoto, T; Hiruma, K; Iwasaki, Y; Matsumoto, H; Saze, Z; Takahashi, K; Yamaguchi, T; Yamashita, Y; Yasutome, M, 2006) |
| " Since clinical studies have demonstrated that bisphosphonates (BPs), specific inhibitors of osteoclastic bone resorption, are beneficial for breast cancer patients with bone metastases, we next examined the effects of UFT combined with the BP zoledronic acid (ZOL) on established bone metastases." | 1.32 | Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer. ( Hata, K; Hiraga, T; Ikeda, F; Tamura, D; Ueda, A; Williams, PJ; Yoneda, T, 2003) |
| " He was treated with pharmacokinetic modulating chemotherapy (PMC) and low-dose CPT-11." | 1.32 | [A case of highly advanced ascending colon cancer with multiple bone and liver metastases and pleuritis carcinomatosa treated with pharmacokinetic modulating chemotherapy and low-dose CPT-11]. ( Aihara, T; Fukuhara, A; Kouno, T; Murayama, M; Nakagawa, K; Nakamura, E; Niida, M; Nishimoto, Y; Nozaki, H; Syouda, S; Watanabe, Y; Yagyu, T; Yasuoka, H, 2004) |
| "We recently established a metastasis model in nude mice using the MKL-4 cell line, a contransfectant of the MCF-7 human breast cancer cell line with fgf-4 and lacZ in which micrometastases in several organs can be quantitatively observed." | 1.30 | Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice. ( Dickson, RB; Fujioka, A; Fukumori, H; Kurebayashi, J; Kurosumi, M; Nukatsuka, M; Saito, H; Sonoo, H; Takeda, S; Unemi, N, 1997) |
| "A 60-year-old man with renal cell carcinoma and metastases to the right 7th rib and L2 vertebra (T2N0M1, OSS) was treated with interferon-alpha and the uracil and tegafur combination following nephrectomy." | 1.29 | A case of posttherapeutic sclerotic change of bone metastasis from renal cell carcinoma which proved histopathologically to be complete response. ( Maehara, Y; Satoh, J; Shibata, Y; Shimizu, TS; Sugihara, S; Uchida, T, 1994) |
| "Treatment of hepatocellular carcinoma with bone metastasis is often ineffective, but this is a rare case showing the clinical effectiveness of oral administration of UFT." | 1.29 | [A case of hepatocellular carcinoma with bone metastasis responding to oral administration of UFT]. ( Chao, C; Imada, T; Maehara, T; Matsumoto, A; Miyazaki, T; Morinaga, S; Takehana, T, 1995) |
| "At the same time, malignant lymphoma of the liver and several bones were disclosed, but these tumors had become remarkably smaller after chemotherapy, radiotherapy and transcatheter hepatic arterial chemoembolization." | 1.29 | [A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy]. ( Fujioka, S; Kato, K; Tomono, H, 1996) |
| "A 66-year-old woman with left breast cancer (medullary carcinoma; T1cN1M0; Stage II A) was treated with breast conserving therapy combined with lumpectomy, radiotherapy, chemotherapy and endocrine therapy beginning in March, 1990." | 1.28 | [A case report of bone metastasis diagnosed by MRI and effectively treated with UFT after breast conserving therapy for breast cancer]. ( Hamada, N; Inomata, T; Nishioka, A; Ogawa, Y; Ogoshi, S; Sawada, A; Tanaka, Y; Terashima, M, 1992) |
| "He was diagnosed as having primary hepatocellular carcinoma with bone metastasis by his high titer (111,683 ng/ml) of serum alpha-fetoprotein, computed tomography and abdominal angiography, and so UFT therapy, 400 mg daily, was instituted." | 1.27 | [A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT]. ( Imai, Y; Inada, M; Inui, Y; Kawata, S; Matsuda, Y; Minami, Y; Miyoshi, S; Noda, S; Saito, R; Tamura, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (11.90) | 18.7374 |
| 1990's | 16 (38.10) | 18.2507 |
| 2000's | 17 (40.48) | 29.6817 |
| 2010's | 3 (7.14) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Moriwaki, T | 1 |
| Fukuoka, S | 1 |
| Taniguchi, H | 1 |
| Takashima, A | 1 |
| Kumekawa, Y | 1 |
| Kajiwara, T | 1 |
| Yamazaki, K | 1 |
| Esaki, T | 1 |
| Makiyama, C | 1 |
| Denda, T | 1 |
| Satake, H | 1 |
| Suto, T | 1 |
| Sugimoto, N | 1 |
| Enomoto, M | 1 |
| Ishikawa, T | 3 |
| Kashiwada, T | 1 |
| Sugiyama, M | 1 |
| Komatsu, Y | 1 |
| Okuyama, H | 1 |
| Baba, E | 1 |
| Sakai, D | 1 |
| Watanabe, T | 1 |
| Tamura, T | 1 |
| Yamashita, K | 1 |
| Gosho, M | 1 |
| Shimada, Y | 1 |
| Shiono, S | 1 |
| Harada, M | 1 |
| Abiko, M | 1 |
| Sato, T | 2 |
| Takanashi, I | 1 |
| Sakurai, T | 2 |
| Umemura, T | 1 |
| Jinta, E | 1 |
| Suzuma, T | 1 |
| Yoshimura, G | 1 |
| Shimizu, S | 1 |
| Suzuki, E | 1 |
| Furuse, J | 1 |
| Ikeda, M | 1 |
| Ishii, H | 1 |
| Okusaka, T | 1 |
| Nakachi, K | 1 |
| Mitsunaga, S | 1 |
| Ueno, H | 1 |
| Morizane, C | 1 |
| Hoshi, S | 2 |
| Ohyama, C | 2 |
| Namiki, S | 1 |
| Hagisawa, S | 2 |
| Satoh, M | 2 |
| Saito, S | 2 |
| Ono, K | 2 |
| Shirasaka, T | 1 |
| Arai, Y | 2 |
| Fukuzaki, A | 1 |
| Hiraga, T | 1 |
| Ueda, A | 1 |
| Tamura, D | 1 |
| Hata, K | 1 |
| Ikeda, F | 1 |
| Williams, PJ | 1 |
| Yoneda, T | 1 |
| TRAPEZNIKOV, NN | 1 |
| AVDEEVA, IA | 1 |
| Yagyu, T | 1 |
| Aihara, T | 1 |
| Murayama, M | 1 |
| Nakamura, E | 1 |
| Nozaki, H | 1 |
| Niida, M | 1 |
| Yasuoka, H | 1 |
| Nishimoto, Y | 1 |
| Watanabe, Y | 1 |
| Syouda, S | 1 |
| Kouno, T | 1 |
| Fukuhara, A | 1 |
| Nakagawa, K | 1 |
| Wei, J | 1 |
| Blum, S | 1 |
| Unger, M | 1 |
| Jarmy, G | 1 |
| Lamparter, M | 1 |
| Geishauser, A | 1 |
| Vlastos, GA | 1 |
| Chan, G | 1 |
| Fischer, KD | 1 |
| Rattat, D | 1 |
| Debatin, KM | 1 |
| Hatzopoulos, AK | 1 |
| Beltinger, C | 1 |
| Watanabe, O | 1 |
| Shimizu, T | 1 |
| Imamura, H | 1 |
| Kinoshita, J | 1 |
| Okabe, T | 1 |
| Ogawa, K | 1 |
| Haga, S | 1 |
| Mizuno, K | 1 |
| Togashi, T | 1 |
| Watanabe, K | 1 |
| Seki, K | 1 |
| Ohta, H | 1 |
| Yoshida, T | 1 |
| Kamimura, T | 1 |
| Matsuoka, T | 1 |
| Morikage, N | 1 |
| Kobayashi, T | 1 |
| Kuga, T | 1 |
| Nakayama, T | 1 |
| Fujii, Y | 1 |
| Hashimoto, T | 1 |
| Arai, K | 1 |
| Iwasaki, Y | 1 |
| Saze, Z | 1 |
| Takahashi, K | 1 |
| Yamaguchi, T | 1 |
| Matsumoto, H | 1 |
| Yasutome, M | 1 |
| Hiruma, K | 1 |
| Yamashita, Y | 1 |
| Idelevich, E | 1 |
| Karminsky, N | 1 |
| Dinerman, M | 1 |
| Katsenelson, RL | 1 |
| Zvi, NB | 1 |
| Baruch, NB | 1 |
| Biran, H | 1 |
| Man, S | 1 |
| Shani, A | 1 |
| Suzumura, K | 1 |
| Ito, N | 1 |
| Nagata, H | 1 |
| Kotake, K | 1 |
| Arikawa, T | 1 |
| Ando, K | 1 |
| Nakao, N | 1 |
| Kurokawa, T | 1 |
| An, J | 1 |
| Nonami, T | 1 |
| Itoh, S | 1 |
| Konishi, Y | 1 |
| Harauchi, D | 1 |
| Shinoto, M | 1 |
| Shimizu, TS | 1 |
| Uchida, T | 1 |
| Shibata, Y | 1 |
| Satoh, J | 1 |
| Sugihara, S | 1 |
| Maehara, Y | 1 |
| Chao, C | 1 |
| Imada, T | 1 |
| Takehana, T | 1 |
| Morinaga, S | 1 |
| Miyazaki, T | 1 |
| Maehara, T | 1 |
| Matsumoto, A | 1 |
| Morimoto, T | 1 |
| Sasa, M | 1 |
| Monden, Y | 1 |
| Sakai, S | 1 |
| Sakai, H | 1 |
| Minami, Y | 2 |
| Kanetake, H | 1 |
| Saito, Y | 1 |
| Daniels, M | 1 |
| Díaz-Rubio, E | 1 |
| Guillem, V | 1 |
| Montero, JM | 1 |
| García-Conde, J | 1 |
| Estapé, J | 1 |
| Martín, M | 1 |
| Herranz, C | 1 |
| Ordoñez, A | 1 |
| Galán, A | 1 |
| Fujita, K | 1 |
| Matsushima, H | 1 |
| Nakano, M | 1 |
| Kaneko, T | 1 |
| Taniwaki, M | 1 |
| Kakusui, M | 1 |
| Imoto, M | 1 |
| Takashima, T | 2 |
| Misawa, S | 1 |
| Kashima, K | 1 |
| Ohta, J | 1 |
| Maruiwa, M | 1 |
| Noutomi, M | 1 |
| Tokuhara, K | 1 |
| Inutsuka, K | 1 |
| Tomono, H | 1 |
| Fujioka, S | 1 |
| Kato, K | 1 |
| Ito, T | 1 |
| Yamada, M | 1 |
| Tanemura, H | 1 |
| Oshita, H | 1 |
| Asano, M | 1 |
| Saji, S | 1 |
| Kurebayashi, J | 1 |
| Nukatsuka, M | 1 |
| Fujioka, A | 1 |
| Saito, H | 1 |
| Takeda, S | 1 |
| Unemi, N | 1 |
| Fukumori, H | 1 |
| Kurosumi, M | 1 |
| Sonoo, H | 1 |
| Dickson, RB | 1 |
| Uehara, T | 1 |
| Yano, T | 1 |
| Kanematsu, T | 1 |
| Terazaki, Y | 1 |
| Kuninaka, S | 1 |
| Fukuyama, Y | 1 |
| Yokoyama, H | 1 |
| Asoh, H | 1 |
| Ichinose, Y | 1 |
| Sadamoto, Y | 1 |
| Koujima, M | 1 |
| Itaba, S | 1 |
| Miyagi, Y | 1 |
| Imamura, M | 1 |
| Motosato, K | 1 |
| Inoue, Y | 1 |
| Siomichi, S | 1 |
| Amagase, Y | 1 |
| Ogawa, Y | 2 |
| Ogisawa, K | 1 |
| Ikeda, K | 1 |
| Nagatsuka, I | 1 |
| Matsumura, Y | 1 |
| Yashiro, M | 1 |
| Onoda, N | 1 |
| Nakata, B | 1 |
| Kato, Y | 1 |
| Hirakawa, K | 1 |
| Kusama, M | 1 |
| Kaise, H | 1 |
| Nakayama, S | 1 |
| Oota, D | 1 |
| Shimizu, H | 1 |
| Aoki, T | 1 |
| Koyanagi, Y | 1 |
| Nishimura, K | 1 |
| Nonomura, N | 1 |
| Ono, Y | 1 |
| Nozawa, M | 1 |
| Fukui, T | 1 |
| Harada, Y | 1 |
| Imazu, T | 1 |
| Takaha, N | 1 |
| Sugao, H | 1 |
| Miki, T | 1 |
| Okuyama, A | 1 |
| Ishihama, H | 1 |
| Nishioka, A | 1 |
| Hamada, N | 1 |
| Terashima, M | 1 |
| Sawada, A | 1 |
| Inomata, T | 1 |
| Tanaka, Y | 1 |
| Ogoshi, S | 1 |
| Shibata, M | 1 |
| Saito, A | 1 |
| Hareyama, M | 1 |
| Morita, K | 1 |
| Taguchi, T | 1 |
| Kanda, K | 1 |
| Waki, S | 1 |
| Uchimura, M | 1 |
| Kida, H | 1 |
| Narita, K | 1 |
| Harada, N | 1 |
| Tsujii, H | 1 |
| Kamada, T | 1 |
| Tsuji, H | 1 |
| Takamura, A | 1 |
| Matsuoka, Y | 1 |
| Usubuchi, H | 1 |
| Irie, G | 1 |
| Endo, F | 1 |
| Ishii, T | 1 |
| Kito, T | 1 |
| Inada, M | 1 |
| Kawata, S | 1 |
| Miyoshi, S | 1 |
| Imai, Y | 1 |
| Saito, R | 1 |
| Noda, S | 1 |
| Tamura, S | 1 |
| Inui, Y | 1 |
| Matsuda, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer[NCT00264420] | Phase 1 | 4 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for uracil and Bone Cancer
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
9 trials available for uracil and Bone Cancer
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma.
Topics: Adrenal Gland Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carci | 2011 |
[Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; | 2004 |
Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplat | 2007 |
[Clinical trial of UFT against disseminated breast cancer].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; | 1984 |
Chemo-endocrine therapy for prostate cancer with bone metastasis. Nagasaki Prostate Cancer Research Group.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone | 1994 |
Phase II trial of UFT activity in pretreated breast cancer patients.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; A | 1993 |
Oral combination of cyclophosphamide, uracil plus tegafur and estramustine for hormone-refractory prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antimetabolites, Antineoplastic | 2001 |
[Clinical results of UFT granule of enteric coating (UFT E granule). Osaka UFT E Granule Study Group].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; B | 1990 |
33 other studies available for uracil and Bone Cancer
| Article | Year |
|---|---|
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 2018 |
[A case of recurrent lung cancer with bone metastases treated with tegafur-uracil and zoledronic acid for long-term survival].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; H | 2014 |
[Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-
Topics: Aged, 80 and over; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; B | 2009 |
[Low-dose cisplatin and UFT for hormone refractory prostate cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Com | 2002 |
Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bio | 2003 |
Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Bo | 2003 |
PRELIMINARY DATA ON REGIONAL CHEMOTHERAPY OF MALIGNANT TUMOURS OF THE EXTREMITIES BY PERFUSION.
Topics: Adolescent; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Child; Chondrosarcoma; Dogs; F | 1964 |
[A case of highly advanced ascending colon cancer with multiple bone and liver metastases and pleuritis carcinomatosa treated with pharmacokinetic modulating chemotherapy and low-dose CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Coloni | 2004 |
Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery.
Topics: Animals; Bone Neoplasms; Bystander Effect; Carcinoma, Lewis Lung; Cell Hypoxia; Cytosine Deaminase; | 2004 |
[A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ri | 2005 |
[A case of colon cancer with multiple liver, lung and bone metastases successfully treated with combined weekly high-dose 5-FU (WHF) chemotherapy with UFT and CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colect | 2005 |
[A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Topics: Adult; Anorexia; Antimetabolites, Antineoplastic; Bone Neoplasms; Cerebral Hemorrhage; Dihydropyrimi | 2006 |
[A case of lumbar metastases from rectal cancer successfully treated by UFT plus oral leucovorin (LV) therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neopla | 2008 |
A case of posttherapeutic sclerotic change of bone metastasis from renal cell carcinoma which proved histopathologically to be complete response.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Diagnostic Im | 1994 |
[A case of hepatocellular carcinoma with bone metastasis responding to oral administration of UFT].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hep | 1995 |
[Improvement of clinical symptoms by UFT and TAM and a case of bone metastasis from breast carcinoma during pregnancy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Hum | 1994 |
[Ifosfamide in combined hormonochemotherapy on prostate cancer].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 1994 |
[Disease-free survival in a patient with squamous cell lung carcinoma following complete response with the combination chemotherapy of cisplatin and etoposide].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, | 1993 |
[A case of advanced gastric cancer responding to chemotherapy and radiotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cispl | 1996 |
[A case of early gastric cancer transformed from adenoma by chemotherapy and radiotherapy].
Topics: Adenoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosp | 1996 |
[Results of combination therapy of UFT-E with low-dose CDDP for patients with advanced recurrent breast cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; B | 1998 |
Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice.
Topics: Animals; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Disease Progression; | 1997 |
[Outpatient chemotherapy with oral UFT (tegafur and uracil) and cisplatin against metastatic non-small cell lung carcinoma--an effective case].
Topics: Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bone Ne | 1999 |
[A case of advanced hepatocellular carcinoma with lung and bone metastases effectively treated by orally administered UFT].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers | 2000 |
[Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplas | 2000 |
[A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bre | 2000 |
[A case of breast cancer with multiple metastases effectively treated with long-term administration of docetaxel, aclarubicin and UFT].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast | 2001 |
[A case report of bone metastasis diagnosed by MRI and effectively treated with UFT after breast conserving therapy for breast cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast N | 1992 |
[A case report of multiple bone metastases of breast carcinoma effectively treated with mild chemo-endocrine therapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms | 1992 |
[A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neopla | 1990 |
Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, | 1989 |
[A case of breast cancer with multiple bone metastases effectively treated with UFT and tamoxifen].
Topics: Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplas | 1989 |
[A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Hepatocellular; Humans; L | 1987 |